HutchMED (China) LIMITED (HMDCF) Free cash flow 2016–2025
HutchMED (China) LIMITED (HMDCF) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$78.8MFY2025 · since FY2016: -$13.9M → -$78.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$78.8M | -352.0% |
| FY2024 | -$17.4M | -109.3% |
| FY2023 | $186.6M | +161.1% |
| FY2022 | -$305.3M | -38.4% |
| FY2021 | -$220.6M | -215.1% |
| FY2020 | -$70.0M | +21.8% |
| FY2019 | -$89.5M | -128.2% |
| FY2018 | -$39.2M | -180.8% |
| FY2017 | -$14.0M | -0.5% |
| FY2016 | -$13.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More HMDCF financial trends
HMDCF RevenueHMDCF Net incomeHMDCF Net marginHMDCF Gross profitHMDCF Gross marginHMDCF Operating incomeHMDCF Operating marginHMDCF Operating cash flowHMDCF Capital expendituresHMDCF Return on equityHMDCF Stock buybacksHMDCF Dividends paidHMDCF Total assetsHMDCF Total liabilitiesHMDCF Shareholders’ equityHMDCF overview →